Please wait while we open this resource.
K
Clinical reviews
Asundexian for Secondary Stroke Prevention
The New England Journal of Medicine
PDF202613 pages699 KB
Patients who have experienced a noncardioembolic ischemic stroke or transient ischemic attack are at a heightened risk for recurrent strokes. The study evaluates whether adding asundexian to standard antiplatelet therapy could provide superior outcomes compared to antiplatelet therapy alone. The findings aim to clarify the role of factor XI inhibition in stroke prevention strategies.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
Traumatic Brain Injury
Same clinical topic · Neurology
Classification of the Epilepsies
Same clinical topic · Neurology
Neuroimaging Patterns of Intracranial Infections: Meningitis, Cerebritis, and Their Complications
Same clinical topic · Neurology
An update on management of subarachnoid haemorrhage
Same clinical topic · Neurology
INCLUSION BODY MYOSITIS
Same clinical topic · Neurology
ENCEPHALITIS
Same clinical topic · Neurology
INTRACEREBRAL HAEMORRHAGE
Same clinical topic · Neurology
INCLUSION BODY MYOSITIS
Same clinical topic · Neurology
PREVENTION OF STROKE
Same clinical topic · Neurology